Amedeo Smart

Free Medical Literature Service



Chronic Heart Failure

  Free Subscription

Articles published in
PLoS One
    January 2021
  1. ISHAK WW, Korouri S, Darwish T, Vanle B, et al
    Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial.
    PLoS One. 2021;16:e0244453.
    >> Share

  2. LU XH, Liu A, Fuh SC, Lian Y, et al
    Recurrent disease progression networks for modelling risk trajectory of heart failure.
    PLoS One. 2021;16:e0245177.
    >> Share

  3. YAMAZAKI R, Nishiyama O, Yoshikawa K, Saeki S, et al
    HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure.
    PLoS One. 2021;16:e0245778.
    >> Share

  4. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Correction: Acute Myocardial Infarction and Acute Heart Failure in the Middle East and North Africa: Study Design and Pilot Phase Study Results from the PEACE MENA Registry.
    PLoS One. 2021;16:e0246036.
    >> Share

  5. KAMATH DY, Bhuvana KB, Salazar LJ, Varghese K, et al
    A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure.
    PLoS One. 2021;16:e0245659.
    >> Share

  6. OGUNTADE AS, Ajayi IO
    Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study.
    PLoS One. 2021;16:e0245734.
    >> Share

  7. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    >> Share

  8. FUNAMIZU T, Nagatomo Y, Saji M, Iguchi N, et al
    Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
    PLoS One. 2021;16:e0247140.
    >> Share

  9. YOLA IM, Oh A, Mitchell GF, O'Connor G, et al
    Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
    PLoS One. 2021;16:e0246355.
    >> Share

  10. PIERCE JB, Shah NS, Petito LC, Pool L, et al
    Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study.
    PLoS One. 2021;16:e0246813.
    >> Share

  11. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    PLoS One. 2021;16:e0247987.
    >> Share

  12. MCHORNEY CA, Mansukhani SG, Anatchkova M, Taylor N, et al
    The impact of heart failure on patients and caregivers: A qualitative study.
    PLoS One. 2021;16:e0248240.
    >> Share

  13. PUWANANT S, Sinphurmsukskul S, Krailak L, Nakaviroj P, et al
    The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure.
    PLoS One. 2021;16:e0249043.
    >> Share

  14. KAWADA K, Fukuda H, Kubo T, Ohta T, et al
    Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
    PLoS One. 2021;16:e0250372.
    >> Share

  15. BAMFORTH RJ, Chhibba R, Ferguson TW, Sabourin J, et al
    Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249542.
    >> Share

  16. ABE D, Inomata T
    Actual state of "triple therapy" for heart failure patients in eight regions of Japan: An analysis of a nationwide medical claims database.
    PLoS One. 2021;16:e0249711.
    >> Share

  17. MBOTWA JL, Kamps M, Baxter PD, Ellison GTH, et al
    Latent class regression improves the predictive acuity and clinical utility of survival prognostication amongst chronic heart failure patients.
    PLoS One. 2021;16:e0243674.
    >> Share

  18. LUPON J, Santiago-Vacas E, Cediel G, Codina P, et al
    Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
    PLoS One. 2021;16:e0249674.
    >> Share

  19. KANDA M, Tateishi K, Nakagomi A, Iwahana T, et al
    Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
    PLoS One. 2021;16:e0251505.
    >> Share

  20. PONGIGLIONE B, Torbica A, Gale CP, Tavazzi L, et al
    Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study.
    PLoS One. 2021;16:e0250931.
    >> Share

  21. ALGUREN B, Jernberg T, Vasko P, Selb M, et al
    Content comparison and person-centeredness of standards for quality improvement in cardiovascular health care.
    PLoS One. 2021;16:e0244874.
    >> Share

  22. ABID L, Charfeddine S, Kammoun I, Ben Halima M, et al
    Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
    PLoS One. 2021;16:e0251658.
    >> Share

  23. CHOU YY, Ward JL, Barron LZ, Murphy SD, et al
    Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: A prospective, observational study.
    PLoS One. 2021;16:e0252544.
    >> Share

  24. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
    Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
    PLoS One. 2021;16:e0253017.
    >> Share

  25. MAHESRI M, Chin K, Kumar A, Barve A, et al
    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    PLoS One. 2021;16:e0252903.
    >> Share

  26. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Cardiac index predicts long-term outcomes in patients with heart failure.
    PLoS One. 2021;16:e0252833.
    >> Share

  27. KATO M, Mori Y, Watanabe D, Onoda H, et al
    Relationship between average daily rehabilitation time and decline in instrumental activity of daily living among older patients with heart failure: A preliminary analysis of a multicenter cohort study, SURUGA-CARE.
    PLoS One. 2021;16:e0254128.
    >> Share

  28. KAWASE Y, Kato T, Morimoto T, Hata R, et al
    Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
    PLoS One. 2021;16:e0253999.
    >> Share

  29. TANIGUCHI C, Seto N, Shimizu Y
    Outpatient nursing support for self-monitoring in patients with chronic heart failure.
    PLoS One. 2021;16:e0254019.
    >> Share

  30. HAMO CE, Abdelmoneim SS, Han SY, Chandy E, et al
    OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    PLoS One. 2021;16:e0253014.
    >> Share

  31. GOLAND S, Volodarsky I, Fabricant Y, Livschitz S, et al
    Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
    PLoS One. 2021;16:e0254104.
    >> Share

  32. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    >> Share

  33. PRATTIPATI S, Sakita FM, Kweka GL, Tarimo TG, et al
    Heart failure care and outcomes in a Tanzanian emergency department: A prospective observational study.
    PLoS One. 2021;16:e0254609.
    >> Share

  34. LOKAJ P, Spinar J, Spinarova L, Malek F, et al
    Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
    PLoS One. 2021;16:e0255271.
    >> Share

  35. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Variable effects of underlying diseases on the prognosis of patients with COVID-19.
    PLoS One. 2021;16:e0254258.
    >> Share

  36. LI CX, Liang S, Gao L, Liu H, et al
    Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    PLoS One. 2021;16:e0244689.
    >> Share

  37. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
    Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
    PLoS One. 2021;16:e0255364.
    >> Share

  38. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    >> Share

  39. ACHARYA R, Patel A, Schultz E, Bourgeois M, et al
    Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.
    PLoS One. 2021;16:e0256368.
    >> Share

  40. BECK-FRIIS J, Leach S, Omerovic E, Zeijlon R, et al
    No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
    PLoS One. 2021;16:e0256035.
    >> Share

    January 2020
  41. LUND A, Nordrehaug JE, Slettom G, Hafstad Solvang SE, et al
    Plasma kynurenines and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0227365.
    >> Share

  42. THOMSON P, Howie K, Leslie SJ, Angus NJ, et al
    Evaluating emotional distress and health-related quality of life in patients with heart failure and their family caregivers: Testing dyadic dynamics using the Actor-Partner Interdependence Model.
    PLoS One. 2020;15:e0227129.
    >> Share

  43. MI-MI L, Farman GP, Mayfield RM, Strom J, et al
    In vivo elongation of thin filaments results in heart failure.
    PLoS One. 2020;15:e0226138.
    >> Share

  44. DI TANNA GL, Wirtz H, Burrows KL, Globe G, et al
    Evaluating risk prediction models for adults with heart failure: A systematic literature review.
    PLoS One. 2020;15:e0224135.
    >> Share

  45. MARTINS MATIAS A, Murucci Coelho P, Bermond Marques V, Dos Santos L, et al
    Hypercaloric diet models do not develop heart failure, but the excess sucrose promotes contractility dysfunction.
    PLoS One. 2020;15:e0228860.
    >> Share

  46. LUND A, Nordrehaug JE, Slettom G, Solvang SH, et al
    Correction: Plasma kynurenines and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0230056.
    >> Share

  47. STOCKIGT F, Eichhorn L, Beiert T, Knappe V, et al
    Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice.
    PLoS One. 2020;15:e0228913.
    >> Share

  48. BRANDT EJ, Ross JS, Grady JN, Ahmad T, et al
    Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures.
    PLoS One. 2020;15:e0230734.
    >> Share

  49. FORRESTER SJ, Dolmatova EV, Griendling KK
    An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study.
    PLoS One. 2020;15:e0225207.
    >> Share

  50. DI ACHILLE P, Parikh J, Khamzin S, Solovyova O, et al
    Model order reduction for left ventricular mechanics via congruency training.
    PLoS One. 2020;15:e0219876.
    >> Share

  51. VELAGALETI RS, Short MI, Larson MG, Vasan RS, et al
    Prognosis of "pre-heart failure" clinical phenotypes.
    PLoS One. 2020;15:e0231254.
    >> Share

  52. ROY B, Wolf JRLM, Carlson MD, Akkermans R, et al
    An international comparison of factors affecting quality of life among patients with congestive heart failure: A cross-sectional study.
    PLoS One. 2020;15:e0231346.
    >> Share

  53. JANKOWSKA-POLANSKA B, Swiatoniowska-Lonc N, Slawuta A, Krowczynska D, et al
    Patient-Reported Compliance in older age patients with chronic heart failure.
    PLoS One. 2020;15:e0231076.
    >> Share

  54. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    >> Share

  55. KANAGALA P, Arnold JR, Singh A, Chan DCS, et al
    Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    PLoS One. 2020;15:e0232280.
    >> Share

  56. LUISO D, Villanueva JA, Belarte-Tornero LC, Fort A, et al
    Surface respiratory electromyography and dyspnea in acute heart failure patients.
    PLoS One. 2020;15:e0232225.
    >> Share

  57. NGUYEN ITN, Brandt MM, van de Wouw J, van Drie RWA, et al
    Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    PLoS One. 2020;15:e0232399.
    >> Share

  58. CLAUSS S, Schuttler D, Bleyer C, Vlcek J, et al
    Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.
    PLoS One. 2020;15:e0232374.
    >> Share

  59. GUYOT P, Djermoune EH, Chenuel B, Bastogne T, et al
    A signal demodulation-based method for the early detection of Cheyne-Stokes respiration.
    PLoS One. 2020;15:e0221191.
    >> Share

  60. JORBA G, Aguirre-Plans J, Junet V, Segu-Verges C, et al
    In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.
    PLoS One. 2020;15:e0228926.
    >> Share

  61. OTANI K, Higa Y, Kitano T, Nabeshima Y, et al
    Prediction of cardiac events using fully automated GLS and BNP titers in patients with known or suspected heart failure.
    PLoS One. 2020;15:e0234294.
    >> Share

  62. YOSHIOKA K, Matsue Y, Okumura T, Kida K, et al
    Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure.
    PLoS One. 2020;15:e0235493.
    >> Share

  63. ONUSKO E, McDermott MR, Robbins N, Liu G, et al
    Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy.
    PLoS One. 2020;15:e0230386.
    >> Share

  64. GROSS C, Fresiello L, Schloglhofer T, Dimitrov K, et al
    Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients' response and cardiorespiratory simulations.
    PLoS One. 2020;15:e0229688.
    >> Share

  65. HARDT F, Becker M, Brandenburg V, Grebe J, et al
    Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis.
    PLoS One. 2020;15:e0229636.
    >> Share

  66. DI TANNA GL, Wirtz H, Burrows KL, Globe G, et al
    Correction: Evaluating risk prediction models for adults with heart failure: A systematic literature review.
    PLoS One. 2020;15:e0235970.
    >> Share

  67. PIEROBON A, Granata N, Torlaschi V, Vailati C, et al
    Psychomotor speed as a predictor of functional status in older chronic heart failure (CHF) patients attending cardiac rehabilitation.
    PLoS One. 2020;15:e0235570.
    >> Share

  68. LOOP MS, Van Dyke MK, Chen L, Brown TM, et al
    Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction.
    PLoS One. 2020;15:e0233161.
    >> Share

  69. HUANG WM, Feng JY, Cheng HM, Chen SZ, et al
    The role of pulmonary function in patients with heart failure and preserved ejection fraction: Looking beyond chronic obstructive pulmonary disease.
    PLoS One. 2020;15:e0235152.
    >> Share

  70. GOTO T, Miyagawa S, Tamai K, Matsuura R, et al
    High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRalpha-positive bone marrow cells.
    PLoS One. 2020;15:e0230392.
    >> Share

  71. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Acute myocardial infarction and acute heart failure in the Middle East and North Africa: Study design and pilot phase study results from the PEACE MENA registry.
    PLoS One. 2020;15:e0236292.
    >> Share

  72. CABRERA-AGUILERA I, Falcones B, Calvo-Fernandez A, Benito B, et al
    The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients.
    PLoS One. 2020;15:e0236923.
    >> Share

  73. PAULUS MG, Meindl C, Bohm L, Holzapfel M, et al
    Predictors of functional improvement in the short term after MitraClip implantation in patients with secondary mitral regurgitation.
    PLoS One. 2020;15:e0232817.
    >> Share

  74. TAMAMURA Y, Matsuura M, Shiba S, Nishikimi T, et al
    Heart failure assessed based on plasma B-type natriuretic peptide (BNP) levels negatively impacts activity of daily living in patients with hip fracture.
    PLoS One. 2020;15:e0237387.
    >> Share

  75. SEID E, Engidawork E, Alebachew M, Mekonnen D, et al
    Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia.
    PLoS One. 2020;15:e0237781.
    >> Share

  76. GARCIMARTIN P, Comin-Colet J, Pardo-Cladellas Y, Badosa N, et al
    Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions.
    PLoS One. 2020;15:e0233338.
    >> Share

  77. MEINDL C, Hochadel M, Frankenstein L, Bruder O, et al
    The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry.
    PLoS One. 2020;15:e0234260.
    >> Share

  78. SAILLARD C, Mallet D, Chow-Chine L, Bisbal M, et al
    Non-invasive ventilation indication for critically ill cancer patients admitted to the intensive care unit for acute respiratory failure (ARF) with associated cardiac dysfunction: Results from an observational study.
    PLoS One. 2020;15:e0234495.
    >> Share

  79. KIM J, Choi J, Shin MS, Kim M, et al
    Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ?
    PLoS One. 2020;15:e0238567.
    >> Share

  80. STROCCHI M, Augustin CM, Gsell MAF, Karabelas E, et al
    A publicly available virtual cohort of four-chamber heart meshes for cardiac electro-mechanics simulations.
    PLoS One. 2020;15:e0235145.
    >> Share

  81. IWAMIYA T, Segard BD, Matsuoka Y, Imamura T, et al
    Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis.
    PLoS One. 2020;15:e0237810.
    >> Share

  82. YOSHIKAWA Y, Tamaki Y, Morimoto T, Yaku H, et al
    Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    PLoS One. 2020;15:e0239100.
    >> Share

  83. FRESIELLO L, Jacobs S, Timmermans P, Buys R, et al
    Limiting factors of peak and submaximal exercise capacity in LVAD patients.
    PLoS One. 2020;15:e0235684.
    >> Share

  84. OKA SI, Sabry AD, Horiuchi AK, Cawley KM, et al
    Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1.
    PLoS One. 2020;15:e0234913.
    >> Share

  85. MIN D, Park JS, Choi EY, Ahn JA, et al
    Comparison of learning needs priorities between healthcare providers and patients with heart failure.
    PLoS One. 2020;15:e0239656.
    >> Share

  86. HU Z, Du D
    A new analytical framework for missing data imputation and classification with uncertainty: Missing data imputation and heart failure readmission prediction.
    PLoS One. 2020;15:e0237724.
    >> Share

  87. PANDEY M, Xu Z, Sholle E, Maliakal G, et al
    Extraction of radiographic findings from unstructured thoracoabdominal computed tomography reports using convolutional neural network based natural language processing.
    PLoS One. 2020;15:e0236827.
    >> Share

  88. BOBILLO-PEREZ S, Girona-Alarcon M, Corniero P, Sole-Ribalta A, et al
    Pro-atrial natriuretic peptide and pro-adrenomedullin before cardiac surgery in children. Can we predict the future?
    PLoS One. 2020;15:e0236377.
    >> Share

  89. BLAZQUEZ-BERMEJO Z, Farre N, Llagostera M, Caravaca Perez P, et al
    The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
    PLoS One. 2020;15:e0240098.
    >> Share

  90. CARABALLO C, McCullough M, Fuery MA, Chouairi F, et al
    COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
    PLoS One. 2020;15:e0238829.
    >> Share

  91. LI AH, Palmer KS, Taljaard M, Paterson JM, et al
    Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study.
    PLoS One. 2020;15:e0236480.
    >> Share

  92. STOLINA M, Luo X, Dwyer D, Han CY, et al
    The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    PLoS One. 2020;15:e0231234.
    >> Share

  93. OKANO T, Motoki H, Minamisawa M, Kimura K, et al
    Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
    PLoS One. 2020;15:e0241003.
    >> Share

  94. LANGSETH MS, Andersen GO, Husebye T, Arnesen H, et al
    Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
    PLoS One. 2020;15:e0241333.
    >> Share

  95. IACCARINO G, Grassi G, Borghi C, Carugo S, et al
    Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.
    PLoS One. 2020;15:e0237297.
    >> Share

  96. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    >> Share

  97. BAVISHI A, Lloyd-Jones DM, Ning H, Vu THT, et al
    Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.
    PLoS One. 2020;15:e0240567.
    >> Share

  98. LIU N, Hang T, Gao X, Yang W, et al
    The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    PLoS One. 2020;15:e0238775.
    >> Share

  99. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    >> Share

  100. SOHN A, Speier W, Lan E, Aoki K, et al
    Integrating remote monitoring into heart failure patients' care regimen: A pilot study.
    PLoS One. 2020;15:e0242210.
    >> Share

  101. MORBACH C, Sahiti F, Tiffe T, Cejka V, et al
    Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study.
    PLoS One. 2020;15:e0239684.
    >> Share

  102. MEZZACAPPA C, Ravindra NG, Caraballo C, Chouairi F, et al
    Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
    PLoS One. 2020;15:e0242928.
    >> Share

  103. CHECA C, Medina-Perucha L, Munoz MA, Verdu-Rotellar JM, et al
    Living with advanced heart failure: A qualitative study.
    PLoS One. 2020;15:e0243974.
    >> Share

  104. TING SW, Fan PC, Lin YS, Lin MS, et al
    Uremic pruritus and long-term morbidities in the dialysis population.
    PLoS One. 2020;15:e0241088.
    >> Share

  105. HAMMOND MM, Shen C, Li S, Kazi DS, et al
    Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience.
    PLoS One. 2020;15:e0244379.
    >> Share

  106. KRUIK-KOLLOFFEL WJ, van der Palen J, Doggen CJM, van Maaren MC, et al
    Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
    PLoS One. 2020;15:e0244231.
    >> Share

  107. VERHESTRAETEN C, Weijers G, Debleu D, Ciarka A, et al
    Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement.
    PLoS One. 2020;15:e0244485.
    >> Share

  108. SATO Y, Yoshihisa A, Watanabe K, Hotsuki Y, et al
    Association between platelet distribution width and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0244608.
    >> Share

  109. KATO T, Yaku H, Morimoto T, Inuzuka Y, et al
    Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study.
    PLoS One. 2020;15:e0243818.
    >> Share

  110. DASSANAYAKA S, Brittian KR, Long BW, Higgins LA, et al
    Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    PLoS One. 2020;15:e0242250.
    >> Share

  111. HER AY, Choi BG, Rha SW, Kim YH, et al
    The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
    PLoS One. 2020;15:e0242314.
    >> Share

  112. DE NATTES T, Litzler PY, Gay A, Nafeh-Bizet C, et al
    Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.
    PLoS One. 2020;15:e0242931.
    >> Share

  113. SALONEN J, Vahanikkila H, Purokivi M, Kaarteenaho R, et al
    Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    PLoS One. 2020;15:e0242860.
    >> Share

  114. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    >> Share

  115. JONES E, Wei J, Nelson MD, Bakir M, et al
    N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    PLoS One. 2020;15:e0243213.
    >> Share

  116. BARENFELD E, Ali L, Wallstrom S, Fors A, et al
    Becoming more of an insider: A grounded theory study on patients' experience of a person-centred e-health intervention.
    PLoS One. 2020;15:e0241801.
    >> Share

  117. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
    Multiscale based nonlinear dynamics analysis of heart rate variability signals.
    PLoS One. 2020;15:e0243441.
    >> Share

    January 2019
  118. WANG ID, Chien WC, Chung CH, Tsai PY, et al
    Non-Apnea Sleep Disorder associates with increased risk of incident heart failure-A nationwide population-based cohort study.
    PLoS One. 2019;14:e0209673.
    >> Share

  119. SILVESTRINI A, Bruno C, Vergani E, Venuti A, et al
    Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study.
    PLoS One. 2019;14:e0210320.
    >> Share

  120. SEID MA, Abdela OA, Zeleke EG
    Adherence to self-care recommendations and associated factors among adult heart failure patients. From the patients' point of view.
    PLoS One. 2019;14:e0211768.
    >> Share

  121. LEE SJ, Ha KH, Lee JH, Lee H, et al
    Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study.
    PLoS One. 2019;14:e0211959.
    >> Share

  122. ZAHID FM, Ramzan S, Faisal S, Hussain I, et al
    Gender based survival prediction models for heart failure patients: A case study in Pakistan.
    PLoS One. 2019;14:e0210602.
    >> Share

  123. TURGEON RD, Kolber MR, Loewen P, Ellis U, et al
    Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    PLoS One. 2019;14:e0212907.
    >> Share

  124. LU Q, Dong N, Wang Q, Yi W, et al
    Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure.
    PLoS One. 2019;14:e0214894.
    >> Share

  125. CHEN TY, Kao CW, Cheng SM, Chang YC, et al
    Correction: Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure.
    PLoS One. 2019;14:e0214825.
    >> Share

  126. SPINAR J, Spinarova L, Malek F, Ludka O, et al
    Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry.
    PLoS One. 2019;14:e0214363.
    >> Share

  127. AMIN A, Garcia Reeves AB, Li X, Dhamane A, et al
    Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
    PLoS One. 2019;14:e0213614.
    >> Share

  128. WU MY, Chen TT, Chen YC, Tarng DC, et al
    Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
    PLoS One. 2019;14:e0215624.
    >> Share

  129. LIN TK, You KX, Hsu CT, Li YD, et al
    Negative affectivity and social inhibition are associated with increased cardiac readmission in patients with heart failure: A preliminary observation study.
    PLoS One. 2019;14:e0215726.
    >> Share

  130. GIL-CAYUELA C, Lopez A, Martinez-Dolz L, Gonzalez-Juanatey JR, et al
    The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy.
    PLoS One. 2019;14:e0215818.
    >> Share

  131. ARGENZIANO MA, Doss MX, Tabler M, Sachinidis A, et al
    Transcriptional changes associated with advancing stages of heart failure underlie atrial and ventricular arrhythmogenesis.
    PLoS One. 2019;14:e0216928.
    >> Share

  132. SHAMALI M, Konradsen H, Stas L, Ostergaard B, et al
    Dyadic effects of perceived social support on family health and family functioning in patients with heart failure and their nearest relatives: Using the Actor-Partner Interdependence Mediation Model.
    PLoS One. 2019;14:e0217970.
    >> Share

  133. HONEYFORD K, Bell D, Chowdhury F, Quint J, et al
    Unscheduled hospital contacts after inpatient discharge: A national observational study of COPD and heart failure patients in England.
    PLoS One. 2019;14:e0218128.
    >> Share

  134. CONTAIFER D JR, Buckley LF, Wohlford G, Kumar NG, et al
    Metabolic modulation predicts heart failure tests performance.
    PLoS One. 2019;14:e0218153.
    >> Share

  135. GRUSTAM AS, Buyukkaramikli N, Koymans R, Vrijhoef HJM, et al
    Value of information analysis in telehealth for chronic heart failure management.
    PLoS One. 2019;14:e0218083.
    >> Share

  136. MILES JA, Quispe R, Mehlman Y, Patel K, et al
    Racial differences and mortality risk in patients with heart failure and hyponatremia.
    PLoS One. 2019;14:e0218504.
    >> Share

  137. MORA MT, Gomez JF, Morley G, Ferrero JM, et al
    Mechanistic investigation of Ca2+ alternans in human heart failure and its modulation by fibroblasts.
    PLoS One. 2019;14:e0217993.
    >> Share

  138. CHEN X, Xin Y, Hu W, Zhao Y, et al
    Quality of life and outcomes in heart failure patients with ejection fractions in different ranges.
    PLoS One. 2019;14:e0218983.
    >> Share

  139. AWAN SE, Bennamoun M, Sohel F, Sanfilippo FM, et al
    Feature selection and transformation by machine learning reduce variable numbers and improve prediction for heart failure readmission or death.
    PLoS One. 2019;14:e0218760.
    >> Share

  140. WANG HW, Ahmad M, Jadayel R, Najjar F, et al
    Inhibition of inflammation by minocycline improves heart failure and depression-like behaviour in rats after myocardial infarction.
    PLoS One. 2019;14:e0217437.
    >> Share

  141. KWON JM, Kim KH, Jeon KH, Lee SE, et al
    Artificial intelligence algorithm for predicting mortality of patients with acute heart failure.
    PLoS One. 2019;14:e0219302.
    >> Share

  142. WANG B, Yang Q, Bai WW, Xing YF, et al
    Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
    PLoS One. 2019;14:e0220845.
    >> Share

  143. RAMALHO SHR, Cipriano Junior G, Vieira PJC, Nakano EY, et al
    Inspiratory muscle strength and six-minute walking distance in heart failure: Prognostic utility in a 10 years follow up cohort study.
    PLoS One. 2019;14:e0220638.
    >> Share

  144. MATSUSHITA K, Sang Y, Yang C, Ballew SH, et al
    Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
    PLoS One. 2019;14:e0219899.
    >> Share

  145. HUANG WM, Sung SH, Yu WC, Cheng HM, et al
    Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction.
    PLoS One. 2019;14:e0220183.
    >> Share

  146. GARCIA-OLMOS L, Aguilar R, Lora D, Carmona M, et al
    Development of a predictive model of hospitalization in primary care patients with heart failure.
    PLoS One. 2019;14:e0221434.
    >> Share

  147. JUNG MH, Kim HL, Choi JH, Lee S, et al
    Heart failure awareness in the Korean general population: Results from the nationwide survey.
    PLoS One. 2019;14:e0222264.
    >> Share

  148. VETROVSKY T, Siranec M, Marencakova J, Tufano JJ, et al
    Validity of six consumer-level activity monitors for measuring steps in patients with chronic heart failure.
    PLoS One. 2019;14:e0222569.
    >> Share

  149. ABEBE TB, Gebreyohannes EA, Tefera YG, Bhagavathula AS, et al
    Correction: The prognosis of heart failure patients: Does sodium level play a significant role?
    PLoS One. 2019;14:e0223007.
    >> Share

  150. GORODESKI EZ, Magnelli-Reyes C, Moennich LA, Grimaldi A, et al
    Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: A novel model of care.
    PLoS One. 2019;14:e0222610.
    >> Share

  151. CHANG TE, Park S, Yang Q, Loustalot F, et al
    Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.
    PLoS One. 2019;14:e0222868.
    >> Share

  152. MOON YJ, Kim JW, Bang YS, Lim YS, et al
    Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.
    PLoS One. 2019;14:e0209100.
    >> Share

  153. SUN CY, Sung JM, Wang JD, Li CY, et al
    A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study.
    PLoS One. 2019;14:e0223336.
    >> Share

  154. BACKHAUS SJ, Metschies G, Billing M, Kowallick JT, et al
    Cardiovascular magnetic resonance imaging feature tracking: Impact of training on observer performance and reproducibility.
    PLoS One. 2019;14:e0210127.
    >> Share

  155. ABU-HALIMA M, Meese E, Saleh MA, Keller A, et al
    Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts.
    PLoS One. 2019;14:e0223606.
    >> Share

  156. ANDERSSON C, Lyass A, Xanthakis V, Larson MG, et al
    Risk factor-based subphenotyping of heart failure in the community.
    PLoS One. 2019;14:e0222886.
    >> Share

  157. LENZI J, Avaldi VM, Molinazzi D, Descovich C, et al
    Are degree of urbanisation and travel times to healthcare services associated with the processes of care and outcomes of heart failure? A retrospective cohort study based on administrative data.
    PLoS One. 2019;14:e0223845.
    >> Share

  158. AXELSEN JB, Andersen S, Sun XQ, Ringgaard S, et al
    Effects of 6-mercaptopurine in pressure overload induced right heart failure.
    PLoS One. 2019;14:e0225122.
    >> Share

  159. HWANG JK, Gwag HB, Park KM, On YK, et al
    Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    PLoS One. 2019;14:e0210603.
    >> Share

  160. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Outcome of patients with heart failure after transcatheter aortic valve implantation.
    PLoS One. 2019;14:e0225473.
    >> Share

  161. GHAZAL F, Theobald H, Rosenqvist M, Al-Khalili F, et al
    Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care.
    PLoS One. 2019;14:e0212974.
    >> Share

  162. DIETL A, Winkel I, Pietrzyk G, Paulus M, et al
    Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition.
    PLoS One. 2019;14:e0225937.
    >> Share

  163. KAUFMANN D, Szwoch M, Kwiatkowska J, Raczak G, et al
    Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction.
    PLoS One. 2019;14:e0225829.
    >> Share

  164. WESTHOFEN S, Jelinek M, Dreher L, Biermann D, et al
    The heterotopic heart transplantation in mice as a small animal model to study mechanical unloading - Establishment of the procedure, perioperative management and postoperative scoring.
    PLoS One. 2019;14:e0214513.
    >> Share

  165. POWER AS, Norman R, Jones TLM, Hickey AJ, et al
    Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
    PLoS One. 2019;14:e0214740.
    >> Share

  166. MAO CT, Chen TH, Tseng CN, Chen SW, et al
    Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
    PLoS One. 2019;14:e0214417.
    >> Share

  167. VAN DEN HOOGEN P, de Jager SCA, Mol EA, Schoneveld AS, et al
    Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.
    PLoS One. 2019;14:e0227283.
    >> Share

  168. SORIMACHI H, Kurosawa K, Yoshida K, Obokata M, et al
    Sex differences in left ventricular afterload and diastolic function are independent from the aortic size.
    PLoS One. 2019;14:e0214907.
    >> Share

  169. DECKX S, Johnson DM, Rienks M, Carai P, et al
    Extracellular SPARC increases cardiomyocyte contraction during health and disease.
    PLoS One. 2019;14:e0209534.
    >> Share

  170. HUANG TL, Hsiao FY, Chiang CK, Shen LJ, et al
    Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
    PLoS One. 2019;14:e0215248.
    >> Share

  171. BRAT K, Stastna N, Merta Z, Olson LJ, et al
    Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome.
    PLoS One. 2019;14:e0215997.
    >> Share

  172. MCCOY IE, Chertow GM, Chang TI
    Patterns of diuretic use in the intensive care unit.
    PLoS One. 2019;14:e0217911.
    >> Share

  173. EGAN BM, Sutherland SE, Tilkemeier PL, Davis RA, et al
    A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions.
    PLoS One. 2019;14:e0217696.
    >> Share

  174. REED ME, Huang J, Brand RJ, Neugebauer R, et al
    Patients with complex chronic conditions: Health care use and clinical events associated with access to a patient portal.
    PLoS One. 2019;14:e0217636.
    >> Share

  175. XUE Y, Xu B, Su C, Han Q, et al
    Cardiorenal syndrome in incident peritoneal dialysis patients: What is its effect on patients' outcomes?
    PLoS One. 2019;14:e0218082.
    >> Share

  176. PARK J, Lee J, Kwon A, Choi HJ, et al
    The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation.
    PLoS One. 2019;14:e0215603.
    >> Share

  177. COZZOLINO F, Montedori A, Abraha I, Eusebi P, et al
    A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
    PLoS One. 2019;14:e0218919.
    >> Share

  178. HAN J, Kubala M, Aranda-Michel E, Trumble DR, et al
    Ventricle-specific epicardial pressures as a means to optimize direct cardiac compression for circulatory support: A pilot study.
    PLoS One. 2019;14:e0219162.
    >> Share

  179. BATLLE M, Castillo N, Alcarraz A, Sarvari S, et al
    Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload.
    PLoS One. 2019;14:e0217926.
    >> Share

  180. SANTOS JUNIOR OR, da Costa Rocha MO, Rodrigues de Almeida F, Sales da Cunha PF, et al
    Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain.
    PLoS One. 2019;14:e0221028.
    >> Share

  181. DELGADO GE, Zirlik A, Gruber R, Scheffold T, et al
    The association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography.
    PLoS One. 2019;14:e0221112.
    >> Share

  182. NGUYEN QL, Wang Y, Helbling N, Simon MA, et al
    Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients.
    PLoS One. 2019;14:e0220490.
    >> Share

  183. ROUBICEK T, Stros J, Kucera P, Nedbal P, et al
    Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    PLoS One. 2019;14:e0219966.
    >> Share

  184. HEARN J, Ssinabulya I, Schwartz JI, Akiteng AR, et al
    Self-management of non-communicable diseases in low- and middle-income countries: A scoping review.
    PLoS One. 2019;14:e0219141.
    >> Share

  185. PHILIP JL, Xu X, Han M, Akhter SA, et al
    Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by beta-arrestins.
    PLoS One. 2019;14:e0219011.
    >> Share

  186. ADELBORG K, Nicolaisen SK, Hasvold P, Palaka E, et al
    Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
    PLoS One. 2019;14:e0218739.
    >> Share

  187. ARANDA-MICHEL E, Waldman LK, Trumble DR
    Left ventricular simulation of cardiac compression: Hemodynamics and regional mechanics.
    PLoS One. 2019;14:e0224475.
    >> Share

  188. BOZKURT S
    Mathematical modeling of cardiac function to evaluate clinical cases in adults and children.
    PLoS One. 2019;14:e0224663.
    >> Share

  189. OUD L
    In-hospital cardiopulmonary resuscitation of patients with cirrhosis: A population-based analysis.
    PLoS One. 2019;14:e0222873.
    >> Share

  190. TAKEJI Y, Taniguchi T, Morimoto T, Saito N, et al
    Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.
    PLoS One. 2019;14:e0222979.
    >> Share

  191. BLANC AL, Fumeaux T, Stirnemann J, Dupuis Lozeron E, et al
    Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients.
    PLoS One. 2019;14:e0219348.
    >> Share

  192. NACHAR W, Merlet N, Maafi F, Shi Y, et al
    Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits.
    PLoS One. 2019;14:e0220707.
    >> Share

  193. MONTENEGRO CAMANHO LE, Benchimol Saad E, Slater C, Oliveira Inacio Junior LA, et al
    Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy.
    PLoS One. 2019;14:e0225612.
    >> Share

  194. AHMED MM, Roukoz H, Trivedi JR, Bhan A, et al
    Questionable utility of digoxin in left-ventricular assist device recipients: A multicenter, retrospective analysis.
    PLoS One. 2019;14:e0225628.
    >> Share

  195. INGRASCIOTTA Y, Sultana J, Giorgianni F, Menditto E, et al
    Analgesic drug use in elderly persons: A population-based study in Southern Italy.
    PLoS One. 2019;14:e0222836.
    >> Share

  196. STEVENS M, Shenoy AV, Munson SH, Yapici HO, et al
    Healthcare utilization and costs of cardiopulmonary complications following cardiac surgery in the United States.
    PLoS One. 2019;14:e0226750.
    >> Share

  197. BERENT TE, Dorschner JM, Meyer T, Craig TA, et al
    Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice.
    PLoS One. 2019;14:e0226440.
    >> Share

  198. OTA Y, Kitamura M, Muta K, Yamashita H, et al
    Effect of statin on life prognosis in Japanese patients undergoing hemodialysis.
    PLoS One. 2019;14:e0224111.
    >> Share

  199. GERGS U, Jahn T, Werner F, Kohler C, et al
    Overexpression of protein phosphatase 5 in the mouse heart: Reduced contractility but increased stress tolerance - Two sides of the same coin?
    PLoS One. 2019;14:e0221289.
    >> Share

    January 2018
  200. LEVIN RK, Katz M, Saldiva PHN, Caixeta A, et al
    Increased hospitalizations for decompensated heart failure and acute myocardial infarction during mild winters: A seven-year experience in the public health system of the largest city in Latin America.
    PLoS One. 2018;13:e0190733.
    >> Share

  201. EGGIMANN L, Blum S, Aeschbacher S, Reusser A, et al
    Risk factors for heart failure hospitalizations among patients with atrial fibrillation.
    PLoS One. 2018;13:e0191736.
    >> Share

  202. MARTIN B, Gabris-Weber BA, Reddy R, Romero G, et al
    Relaxin reverses inflammatory and immune signals in aged hearts.
    PLoS One. 2018;13:e0190935.
    >> Share

  203. AMAR A, Zlochiver S, Barnea O
    Mechano-electric feedback effects in a three-dimensional (3D) model of the contracting cardiac ventricle.
    PLoS One. 2018;13:e0191238.
    >> Share

  204. PUJADES-RODRIGUEZ M, Guttmann OP, Gonzalez-Izquierdo A, Duyx B, et al
    Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
    PLoS One. 2018;13:e0191214.
    >> Share

  205. VALLABHAJOSYULA S, Sakhuja A, Geske JB, Kumar M, et al
    Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: An eight-year cohort study.
    PLoS One. 2018;13:e0190965.
    >> Share

  206. KITAGAWA T, Oda N, Mizukawa M, Hidaka T, et al
    Hospitalization and medical cost of patients with elevated serum N-terminal pro-brain natriuretic peptide levels.
    PLoS One. 2018;13:e0190979.
    >> Share

  207. MLAKAR M, Puddu PE, Somrak M, Bonfiglio S, et al
    Mining telemonitored physiological data and patient-reported outcomes of congestive heart failure patients.
    PLoS One. 2018;13:e0190323.
    >> Share

  208. BECHER PM, Hinrichs S, Fluschnik N, Hennigs JK, et al
    Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.
    PLoS One. 2018;13:e0193844.
    >> Share

  209. GOTSMAN I, Shauer A, Elizur Y, Zwas DR, et al
    Temporal changes in electrocardiographic frontal QRS-T angle and survival in patients with heart failure.
    PLoS One. 2018;13:e0194520.
    >> Share

  210. BASSAND JP, Accetta G, Al Mahmeed W, Corbalan R, et al
    Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
    PLoS One. 2018;13:e0191592.
    >> Share

  211. NIRSCHL JJ, Janowczyk A, Peyster EG, Frank R, et al
    A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue.
    PLoS One. 2018;13:e0192726.
    >> Share

  212. PAN G, Munukutla S, Kar A, Gardinier J, et al
    Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
    PLoS One. 2018;13:e0195796.
    >> Share

  213. CHEN YJ, Wang JS, Hsu CC, Lin PJ, et al
    Cerebral desaturation in heart failure: Potential prognostic value and physiologic basis.
    PLoS One. 2018;13:e0196299.
    >> Share

  214. UMINSKI K, Komenda P, Whitlock R, Ferguson T, et al
    Effect of post-discharge virtual wards on improving outcomes in heart failure and non-heart failure populations: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0196114.
    >> Share

  215. AWAN I, Aziz W, Shah IH, Habib N, et al
    Studying the dynamics of interbeat interval time series of healthy and congestive heart failure subjects using scale based symbolic entropy analysis.
    PLoS One. 2018;13:e0196823.
    >> Share

  216. FLUSCHNIK N, Ojeda F, Zeller T, Jorgensen T, et al
    Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    PLoS One. 2018;13:e0197497.
    >> Share

  217. OKUHARA Y, Asakura M, Azuma K, Orihara Y, et al
    Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
    PLoS One. 2018;13:e0199263.
    >> Share

  218. NAYYAR S, Suszko A, Porta-Sanchez A, Dalvi R, et al
    Reduced T wave alternans in heart failure responders to cardiac resynchronization therapy: Evidence of electrical remodeling.
    PLoS One. 2018;13:e0199637.
    >> Share

  219. CAVALCANTE DFB, Brizon VSC, Probst LF, Meneghim MC, et al
    Did the Family Health Strategy have an impact on indicators of hospitalizations for stroke and heart failure? Longitudinal study in Brazil: 1998-2013.
    PLoS One. 2018;13:e0198428.
    >> Share

  220. MA QQ, Fan XD, Li T, Hao YY, et al
    Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0193857.
    >> Share

  221. DI CARLO A, Lamassa M, Franceschini M, Bovis F, et al
    Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study.
    PLoS One. 2018;13:e0194786.
    >> Share

  222. SETHI NJ, Nielsen EE, Safi S, Feinberg J, et al
    Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    PLoS One. 2018;13:e0193924.
    >> Share

  223. LIN J, Qin Z, Qian H, Li Y, et al
    A novel catheter with retractable stent that can prevent aortic insufficiency during left ventricular assist.
    PLoS One. 2018;13:e0194658.
    >> Share

  224. HAN BG, Song SH, Yoo JS, Park H, et al
    Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.
    PLoS One. 2018;13:e0195202.
    >> Share

  225. XIAO C, Ma T, Dieng AB, Blei DM, et al
    Readmission prediction via deep contextual embedding of clinical concepts.
    PLoS One. 2018;13:e0195024.
    >> Share

  226. BARBIERI F, Dichtl W, Heidbreder A, Brandauer E, et al
    Sleep apnea detection by a cardiac resynchronization device integrated thoracic impedance sensor: A validation study against the gold standard polysomnography.
    PLoS One. 2018;13:e0195573.
    >> Share

  227. DALGAARD F, Ruwald MH, Lindhardt TB, Gislason GH, et al
    Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.
    PLoS One. 2018;13:e0195175.
    >> Share

  228. PARK J, Kim J, Kwon JH, Park SJ, et al
    Association between perioperative beta-blocker use and clinical outcome of non-cardiac surgery in coronary revascularized patients without severe ventricular dysfunction or heart failure.
    PLoS One. 2018;13:e0201311.
    >> Share

  229. CLEMENTY N, Garcia B, Andre C, Bisson A, et al
    Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.
    PLoS One. 2018;13:e0201517.
    >> Share

  230. YE L, Su L, Wang C, Loo S, et al
    Truncations of the titin Z-disc predispose to a heart failure with preserved ejection phenotype in the context of pressure overload.
    PLoS One. 2018;13:e0201498.
    >> Share

  231. KOHLI P, Staziaki PV, Janjua SA, Addison DA, et al
    The effect of emphysema on readmission and survival among smokers with heart failure.
    PLoS One. 2018;13:e0201376.
    >> Share

  232. ANDENAES K, Lunde IG, Mohammadzadeh N, Dahl CP, et al
    The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
    PLoS One. 2018;13:e0201422.
    >> Share

  233. LOKHANDWALA S, McCague N, Chahin A, Escobar B, et al
    One-year mortality after recovery from critical illness: A retrospective cohort study.
    PLoS One. 2018;13:e0197226.
    >> Share

  234. CHEN KH, Chen YT, Yeh SL, Weng LC, et al
    Changes in quality of life and health status in patients with extracorporeal life support: A prospective longitudinal study.
    PLoS One. 2018;13:e0196778.
    >> Share

  235. MESSNER M, Ghadge SK, Goetsch V, Wimmer A, et al
    Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy.
    PLoS One. 2018;13:e0196739.
    >> Share

  236. WEERAHANDI H, Ziaeian B, Fogerty RL, Jenq GY, et al
    Predictors for patients understanding reason for hospitalization.
    PLoS One. 2018;13:e0196479.
    >> Share

  237. HARA T, Nishimura S, Yamamoto T, Kajimoto Y, et al
    TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.
    PLoS One. 2018;13:e0202176.
    >> Share

  238. VAN DEN BERGE JC, Constantinescu AA, van Domburg RT, Brankovic M, et al
    Renal function and anemia in relation to short- and long-term prognosis of patients with acute heart failure in the period 1985-2008: A clinical cohort study.
    PLoS One. 2018;13:e0201714.
    >> Share

  239. BOIVIN-JAHNS V, Uhland K, Holthoff HP, Beyersdorf N, et al
    Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.
    PLoS One. 2018;13:e0201160.
    >> Share

  240. DUBROCK HM, AbouEzzeddine OF, Redfield MM
    High-sensitivity C-reactive protein in heart failure with preserved ejection fraction.
    PLoS One. 2018;13:e0201836.
    >> Share

  241. FORS A, Blanck E, Ali L, Ekberg-Jansson A, et al
    Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure - A randomized controlled trial.
    PLoS One. 2018;13:e0203031.
    >> Share

  242. PAN G, Munukutla S, Kar A, Gardinier J, et al
    Correction: Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
    PLoS One. 2018;13:e0203581.
    >> Share

  243. STRAUSS E, Tomczak J, Staniszewski R, Oszkinis G, et al
    Associations and interactions between variants in selenoprotein genes, selenoprotein levels and the development of abdominal aortic aneurysm, peripheral arterial disease, and heart failure.
    PLoS One. 2018;13:e0203350.
    >> Share

  244. ELCHINOVA E, Teubel I, Roura S, Fernandez MA, et al
    Circulating monocyte subsets and heart failure prognosis.
    PLoS One. 2018;13:e0204074.
    >> Share

  245. VANNINEN SUM, Leivo K, Seppala EH, Aalto-Setala K, et al
    Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure.
    PLoS One. 2018;13:e0203422.
    >> Share

  246. WU WT, Chu CY, Hsu PC, Lee WH, et al
    Impact of the duration of the evidence-based medicine use in acute heart failure: A nationwide cohort study.
    PLoS One. 2018;13:e0205440.
    >> Share

  247. GUAY CA, Morin-Thibault LV, Bonnet S, Lacasse Y, et al
    Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204610.
    >> Share

  248. LIU L, Zhao W, Liu J, Gan Y, et al
    Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice.
    PLoS One. 2018;13:e0205123.
    >> Share

  249. LAKHANI HV, Khanal T, Gabi A, Yousef G, et al
    Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population.
    PLoS One. 2018;13:e0205329.
    >> Share

  250. NIRIAYO YL, Kumela K, Kassa TD, Angamo MT, et al
    Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia.
    PLoS One. 2018;13:e0206120.
    >> Share

  251. PEARSON MJ, Smart NA
    Reported methods for handling missing change standard deviations in meta-analyses of exercise therapy interventions in patients with heart failure: A systematic review.
    PLoS One. 2018;13:e0205952.
    >> Share

  252. ABEBE TB, Gebreyohannes EA, Tefera YG, Bhagavathula AS, et al
    The prognosis of heart failure patients: Does sodium level play a significant role?
    PLoS One. 2018;13:e0207242.
    >> Share

  253. TAKIMURA H, Hada T, Kawano M, Yabe T, et al
    A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.
    PLoS One. 2018;13:e0207481.
    >> Share

  254. AU-YEUNG WM, Reinhall PG, Bardy GH, Brunton SL, et al
    Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data.
    PLoS One. 2018;13:e0207215.
    >> Share

  255. CHEN TY, Kao CW, Cheng SM, Chang YC, et al
    Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure.
    PLoS One. 2018;13:e0205953.
    >> Share

  256. PAVO N, Yarragudi R, Puttinger H, Arfsten H, et al
    Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    PLoS One. 2018;13:e0206830.
    >> Share

  257. KHANAM SS, Choi E, Son JW, Lee JW, et al
    Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    PLoS One. 2018;13:e0206380.
    >> Share

  258. MEZZANI A, Pistono M, Agostoni P, Giordano A, et al
    Exercise gas exchange in continuous-flow left ventricular assist device recipients.
    PLoS One. 2018;13:e0187112.
    >> Share

  259. CHO JY, Kim KH, Cho HJ, Lee HY, et al
    Nutritional risk index as a predictor of mortality in acutely decompensated heart failure.
    PLoS One. 2018;13:e0209088.
    >> Share

  260. COPS J, Mullens W, Verbrugge FH, Swennen Q, et al
    Selective abdominal venous congestion to investigate cardiorenal interactions in a rat model.
    PLoS One. 2018;13:e0197687.
    >> Share

  261. DUBIN RF, Whooley M, Pico A, Ganz P, et al
    Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study.
    PLoS One. 2018;13:e0208042.
    >> Share

  262. CHO H, Oh SH, Lee H, Cho HJ, et al
    The incremental economic burden of heart failure: A population-based investigation from South Korea.
    PLoS One. 2018;13:e0208731.
    >> Share

  263. CARAVITA S, Faini A, Carolino D'Araujo S, Dewachter C, et al
    Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    PLoS One. 2018;13:e0199164.
    >> Share

  264. BLAIN AM, Greally E, McClorey G, Manzano R, et al
    Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
    PLoS One. 2018;13:e0198897.
    >> Share

  265. BOKSLAG A, Franssen C, Alma LJ, Kovacevic I, et al
    Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study.
    PLoS One. 2018;13:e0198908.
    >> Share

  266. KARUPPAGOUNDER V, Bajpai A, Meng S, Arumugam S, et al
    Small molecule disruption of G protein betagamma subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
    PLoS One. 2018;13:e0200697.
    >> Share

  267. RAMCHAND J, Patel SK, Srivastava PM, Farouque O, et al
    Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.
    PLoS One. 2018;13:e0198144.
    >> Share

  268. SANDSTEDT M, Rotter Sopasakis V, Lundqvist A, Vukusic K, et al
    Hypoxic cardiac fibroblasts from failing human hearts decrease cardiomyocyte beating frequency in an ALOX15 dependent manner.
    PLoS One. 2018;13:e0202693.
    >> Share

  269. DAHROUGE S, Kaczorowski J, Dolovich L, Paterson M, et al
    Long term outcomes of cluster randomized trial to improve cardiovascular health at population level: The Cardiovascular Health Awareness Program (CHAP).
    PLoS One. 2018;13:e0201802.
    >> Share

  270. SANDGREN E, Rorsman C, Edvardsson N, Engdahl J, et al
    Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.
    PLoS One. 2018;13:e0203661.
    >> Share

  271. LASTRUCCI V, D'Arienzo S, Collini F, Lorini C, et al
    Diagnosis-related differences in the quality of end-of-life care: A comparison between cancer and non-cancer patients.
    PLoS One. 2018;13:e0204458.
    >> Share

  272. OYENUGA AO, Couper D, Matsushita K, Boerwinkle E, et al
    Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
    PLoS One. 2018;13:e0205310.
    >> Share

  273. RYSINSKA A, Skoldenberg O, Garland A, Rolfson O, et al
    Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study.
    PLoS One. 2018;13:e0204391.
    >> Share

  274. SCHUMACHER K, Buttner P, Dagres N, Sommer P, et al
    Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.
    PLoS One. 2018;13:e0206933.
    >> Share

  275. ZOPPINI G, Bergamini C, Mantovani A, Dauriz M, et al
    The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.
    PLoS One. 2018;13:e0209794.
    >> Share

    January 2017
  276. GROIS L, Hupf J, Reinders J, Schroder J, et al
    Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure.
    PLoS One. 2017;12:e0169743.
    >> Share

  277. PELLO LAZARO AM, Cristobal C, Franco-Pelaez JA, Tarin N, et al
    Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.
    PLoS One. 2017;12:e0169826.
    >> Share

  278. ARCOPINTO M, Salzano A, Giallauria F, Bossone E, et al
    Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the T.O.S.CA. GHD Study.
    PLoS One. 2017;12:e0170058.
    >> Share

  279. TUNG YC, Chang GM, Chang HY, Yu TH, et al
    Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure.
    PLoS One. 2017;12:e0170061.
    >> Share

  280. PATEL B, Ismahil MA, Hamid T, Bansal SS, et al
    Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure.
    PLoS One. 2017;12:e0170781.
    >> Share

  281. AL-GOBARI M, Le HH, Fall M, Gueyffier F, et al
    No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0171168.
    >> Share

  282. MASCHERBAUER J, Kammerlander AA, Zotter-Tufaro C, Aschauer S, et al
    Presence of isolated tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.
    PLoS One. 2017;12:e0171542.
    >> Share

  283. FARRE N, Vela E, Cleries M, Bustins M, et al
    Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.
    PLoS One. 2017;12:e0172745.
    >> Share

  284. VALBUSA F, Bonapace S, Agnoletti D, Scala L, et al
    Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
    PLoS One. 2017;12:e0173398.
    >> Share

  285. NAGA PRASAD SV, Gupta MK, Duan ZH, Surampudi VS, et al
    A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.
    PLoS One. 2017;12:e0170456.
    >> Share

  286. KAMO T, Akazawa H, Suda W, Saga-Kamo A, et al
    Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.
    PLoS One. 2017;12:e0174099.
    >> Share

  287. GLEESON S, Liao YW, Dugo C, Cave A, et al
    ECG-derived spatial QRS-T angle is associated with ICD implantation, mortality and heart failure admissions in patients with LV systolic dysfunction.
    PLoS One. 2017;12:e0171069.
    >> Share

  288. RIBA A, Deres L, Eros K, Szabo A, et al
    Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure.
    PLoS One. 2017;12:e0175195.
    >> Share

  289. TAKASHIO S, Nagai T, Sugano Y, Honda S, et al
    Persistent increase in cardiac troponin T at hospital discharge predicts repeat hospitalization in patients with acute decompensated heart failure.
    PLoS One. 2017;12:e0173336.
    >> Share

  290. IVANOV A, Mohamed A, Asfour A, Ho J, et al
    Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.
    PLoS One. 2017;12:e0173245.
    >> Share

  291. Correction: Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction.
    PLoS One. 2017;12:e0176942.
    >> Share

  292. YIN FH, Fan CL, Guo YY, Zhu H, et al
    The impact of gender difference on clinical and echocardiographic outcomes in patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176248.
    >> Share

  293. ICHIKAWA Y, Zemljic-Harpf AE, Zhang Z, McKirnan MD, et al
    Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits.
    PLoS One. 2017;12:e0177660.
    >> Share

  294. VEGTER EL, Ovchinnikova ES, Sillje HHW, Meems LMG, et al
    Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
    PLoS One. 2017;12:e0177242.
    >> Share

  295. STRAM AR, Wagner GR, Fogler BD, Pride PM, et al
    Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.
    PLoS One. 2017;12:e0178354.
    >> Share

  296. ALBADRI A, Lai K, Wei J, Landes S, et al
    Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    PLoS One. 2017;12:e0177684.
    >> Share

  297. GASPERONI F, Ieva F, Barbati G, Scagnetto A, et al
    Multi-state modelling of heart failure care path: A population-based investigation from Italy.
    PLoS One. 2017;12:e0179176.
    >> Share

  298. BREEDT E, Lacerda L, Essop MF
    Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.
    PLoS One. 2017;12:e0179509.
    >> Share

  299. HAN Z, Chen Z, Lan R, Di W, et al
    Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy.
    PLoS One. 2017;12:e0180513.
    >> Share

  300. NGUYEN UC, Maffessanti F, Mafi-Rad M, Conte G, et al
    Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients.
    PLoS One. 2017;12:e0180637.
    >> Share

  301. AHMAD T, Munir A, Bhatti SH, Aftab M, et al
    Survival analysis of heart failure patients: A case study.
    PLoS One. 2017;12:e0181001.
    >> Share

  302. PUNCHIK B, Komarov R, Gavrikov D, Semenov A, et al
    Can home care for homebound patients with chronic heart failure reduce hospitalizations and costs?
    PLoS One. 2017;12:e0182148.
    >> Share

  303. MONTGOMERY MD, Chan T, Swigart PM, Myagmar BE, et al
    An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice.
    PLoS One. 2017;12:e0168409.
    >> Share

  304. MATSUSHITA K, Kwak L, Hyun N, Bessel M, et al
    Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.
    PLoS One. 2017;12:e0181373.
    >> Share

  305. LORIN J, Guilland JC, Stamboul K, Guenancia C, et al
    Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
    PLoS One. 2017;12:e0169979.
    >> Share

  306. ETTINGER G, Burton JP, Gloor GB, Reid G, et al
    Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75).
    PLoS One. 2017;12:e0168622.
    >> Share

  307. FELDMANN C, Zayat R, Goetzenich A, Aljalloud A, et al
    Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
    PLoS One. 2017;12:e0171029.
    >> Share

  308. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    >> Share

  309. KUSAKARI Y, Urashima T, Shimura D, Amemiya E, et al
    Impairment of Excitation-Contraction Coupling in Right Ventricular Hypertrophied Muscle with Fibrosis Induced by Pulmonary Artery Banding.
    PLoS One. 2017;12:e0169564.
    >> Share

  310. YANG X, Liu L, Hao Q, Zou D, et al
    Development and Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Assay for Quantitative Detection of NT-proBNP in Blood.
    PLoS One. 2017;12:e0171376.
    >> Share

  311. WEI W, Liao H, Xue Y, Fang X, et al
    Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience.
    PLoS One. 2017;12:e0169863.
    >> Share

  312. RAMACHANDRAN S, Lowenthal A, Ritner C, Lowenthal S, et al
    Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease.
    PLoS One. 2017;12:e0183624.
    >> Share

  313. GANGA HV, Leung A, Jantz J, Choudhary G, et al
    Supervised exercise training versus usual care in ambulatory patients with left ventricular assist devices: A systematic review.
    PLoS One. 2017;12:e0174323.
    >> Share

  314. KREUSSER MM, Lehmann LH, Haass M, Buss SJ, et al
    Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter.
    PLoS One. 2017;12:e0172070.
    >> Share

  315. MCDERMOTT-ROE C, Leleu M, Rowe GC, Palygin O, et al
    Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function.
    PLoS One. 2017;12:e0170458.
    >> Share

  316. KIM J, Hwang J, Choi JH, Choi HI, et al
    Frequency and clinical impact of retained implantable cardioverter defibrillator lead materials in heart transplant recipients.
    PLoS One. 2017;12:e0176925.
    >> Share

  317. WONG CS, Lin YC, Sung LC, Chen TT, et al
    Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan.
    PLoS One. 2017;12:e0176465.
    >> Share

  318. WU MY, Chen TT, Chen YC, Tarng DC, et al
    Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
    PLoS One. 2017;12:e0184380.
    >> Share

  319. WANG B, Xu M, Li W, Li X, et al
    Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via beta3-AR-nNOS-NO activation.
    PLoS One. 2017;12:e0179648.
    >> Share

  320. GRANDNER MA, Winkelman JW
    Nocturnal leg cramps: Prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factors.
    PLoS One. 2017;12:e0178465.
    >> Share

  321. SHAQURA M, Mohamed DM, Aboryag NB, Bedewi L, et al
    Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats.
    PLoS One. 2017;12:e0184161.
    >> Share

  322. FRESIELLO L, Rademakers F, Claus P, Ferrari G, et al
    Exercise physiology with a left ventricular assist device: Analysis of heart-pump interaction with a computational simulator.
    PLoS One. 2017;12:e0181879.
    >> Share

  323. ALGHAMDI M, Al-Mallah M, Keteyian S, Brawner C, et al
    Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project.
    PLoS One. 2017;12:e0179805.
    >> Share

  324. SON MK, Lim NK, Kim HW, Park HY, et al
    Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    PLoS One. 2017;12:e0179687.
    >> Share

  325. LEE MS, Kuo LL, Tan EC, Lee OK, et al
    Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study.
    PLoS One. 2017;12:e0179307.
    >> Share

  326. KOHARA M, Masuda T, Shiizaki K, Akimoto T, et al
    Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.
    PLoS One. 2017;12:e0178971.
    >> Share

  327. NAMUKWAYA E, Murray SA, Downing J, Leng M, et al
    'I think my body has become addicted to those tablets'. Chronic heart failure patients' understanding of and beliefs about their illness and its treatment: A qualitative longitudinal study from Uganda.
    PLoS One. 2017;12:e0182876.
    >> Share

  328. KEDDIS MT, El-Zoghby Z, Kaplan B, Meeusen JW, et al
    Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.
    PLoS One. 2017;12:e0181123.
    >> Share

  329. SHIN MS, An M, Kim S, Shim JL, et al
    Concomitant diastolic dysfunction further interferes with cognitive performance in moderate to severe systolic heart failure.
    PLoS One. 2017;12:e0184981.
    >> Share

  330. RUDEBUSCH J, Benkner A, Poesch A, Dorr M, et al
    Dynamic adaptation of myocardial proteome during heart failure development.
    PLoS One. 2017;12:e0185915.
    >> Share

  331. RACCA V, Castiglioni P, Panzarino C, Oliva F, et al
    End-stage heart failure: Two surgical approaches with different rehabilitative outcomes.
    PLoS One. 2017;12:e0185717.
    >> Share

  332. RAMIREZ J, Orini M, Minchole A, Monasterio V, et al
    Sudden cardiac death and pump failure death prediction in chronic heart failure by combining ECG and clinical markers in an integrated risk model.
    PLoS One. 2017;12:e0186152.
    >> Share

  333. MATONE A, Derlindati E, Marchetti L, Spigoni V, et al
    Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
    PLoS One. 2017;12:e0182559.
    >> Share

  334. BORNHEIMER R, Shea KM, Sato R, Weycker D, et al
    Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease.
    PLoS One. 2017;12:e0184877.
    >> Share

  335. KIM JS, Yang JW, Yoo JS, Choi SO, et al
    Association between E/e ratio and fluid overload in patients with predialysis chronic kidney disease.
    PLoS One. 2017;12:e0184764.
    >> Share

  336. BAKER J, White N, Mengersen K, Rolfe M, et al
    Joint modelling of potentially avoidable hospitalisation for five diseases accounting for spatiotemporal effects: A case study in New South Wales, Australia.
    PLoS One. 2017;12:e0183653.
    >> Share

  337. YAGYU T, Kumada M, Nakagawa T
    Novel risk stratification with time course assessment of in-hospital mortality in patients with acute heart failure.
    PLoS One. 2017;12:e0187410.
    >> Share

  338. SILVA FH, Veiga FJR, Mora AG, Heck RS, et al
    A novel experimental model of erectile dysfunction in rats with heart failure using volume overload.
    PLoS One. 2017;12:e0187083.
    >> Share

  339. MORA MT, Ferrero JM, Romero L, Trenor B, et al
    Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure.
    PLoS One. 2017;12:e0187739.
    >> Share

  340. PFISTER R, Ihle P, Mews B, Kohnen E, et al
    Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants.
    PLoS One. 2017;12:e0187358.
    >> Share

  341. GORODESKI EZ, Joyce E, Gandesbery BT, Blackstone EH, et al
    Discordance between 'actual' and 'scheduled' check-in times at a heart failure clinic.
    PLoS One. 2017;12:e0187849.
    >> Share

  342. XIA T, Chai X, Shen J
    Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss.
    PLoS One. 2017;12:e0187804.
    >> Share

  343. SAVIRA F, Cao L, Wang I, Yang W, et al
    Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome.
    PLoS One. 2017;12:e0187459.
    >> Share

  344. GHITH N, Frolich A, Merlo J
    The role of the clinical departments for understanding patient heterogeneity in one-year mortality after a diagnosis of heart failure: A multilevel analysis of individual heterogeneity for profiling provider outcomes.
    PLoS One. 2017;12:e0189050.
    >> Share

  345. YEH HM, Lin TT, Yeh CF, Huang HS, et al
    Biomarkers and echocardiography for evaluating the improvement of the ventricular diastolic function after surgical relief of hydronephrosis.
    PLoS One. 2017;12:e0188597.
    >> Share

  346. TRIPATHI R, Sullivan R, Fan TM, Wang D, et al
    Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
    PLoS One. 2017;12:e0189315.
    >> Share

  347. BONDAR G, Togashi R, Cadeiras M, Schaenman J, et al
    Association between preoperative peripheral blood mononuclear cell gene expression profiles, early postoperative organ function recovery potential and long-term survival in advanced heart failure patients undergoing mechanical circulatory support.
    PLoS One. 2017;12:e0189420.
    >> Share

  348. PRADO FP, Dos Santos DO, Blefari V, Silva CA, et al
    Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure.
    PLoS One. 2017;12:e0189469.
    >> Share

  349. KIM SH, Kim HJ, Han S, Yoo BS, et al
    The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.
    PLoS One. 2017;12:e0188938.
    >> Share

  350. BAUTERS C, Dubois E, Porouchani S, Saloux E, et al
    Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.
    PLoS One. 2017;12:e0188884.
    >> Share

  351. KLAUKE B, Gaertner-Rommel A, Schulz U, Kassner A, et al
    High proportion of genetic cases in patients with advanced cardiomyopathy including a novel homozygous Plakophilin 2-gene mutation.
    PLoS One. 2017;12:e0189489.
    >> Share

    January 2016
  352. HSIAO SH, Chiou KR
    Diastolic Heart Failure Predicted by Left Atrial Expansion Index in Patients with Severe Diastolic Dysfunction.
    PLoS One. 2016;11:e0162599.
    >> Share

  353. CHA YS, Lee KH, Lee JW, Kwon W, et al
    The Usefulness of the Delta Neutrophil Index for Predicting Superimposed Pneumonia in Patients with Acute Decompensated Heart Failure in the Emergency Department.
    PLoS One. 2016;11:e0163461.
    >> Share

  354. NELVEG-KRISTENSEN KE, Bie P, Ferrero L, Bjerre D, et al
    Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors.
    PLoS One. 2016;11:e0163341.
    >> Share

  355. KRUMHOLZ HM, Hsieh A, Dreyer RP, Welsh J, et al
    Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia.
    PLoS One. 2016;11:e0160492.
    >> Share

  356. DUFLOS CM, Solecki K, Papinaud L, Georgescu V, et al
    The Intensity of Primary Care for Heart Failure Patients: A Determinant of Readmissions? The CarPaths Study: A French Region-Wide Analysis.
    PLoS One. 2016;11:e0163268.
    >> Share

  357. SHINODA Y, Tagashira H, Bhuiyan MS, Hasegawa H, et al
    Corticosteroids Mediate Heart Failure-Induced Depression through Reduced sigma1-Receptor Expression.
    PLoS One. 2016;11:e0163992.
    >> Share

  358. ZITTERMANN A, Ernst JB, Pilz S, Dreier J, et al
    Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device.
    PLoS One. 2016;11:e0164459.
    >> Share

  359. ABBASI SA, Shah RV, McNulty SE, Hernandez AF, et al
    Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.
    PLoS One. 2016;11:e0164914.
    >> Share

  360. NAGAI T, Honda Y, Sugano Y, Nishimura K, et al
    Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
    PLoS One. 2016;11:e0165841.
    >> Share

  361. CHEN W, Zheng L, Li K, Wang Q, et al
    A Novel and Effective Method for Congestive Heart Failure Detection and Quantification Using Dynamic Heart Rate Variability Measurement.
    PLoS One. 2016;11:e0165304.
    >> Share

  362. YOKOTA J, Ogawa Y, Yamanaka S, Takahashi Y, et al
    Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure.
    PLoS One. 2016;11:e0167326.
    >> Share

  363. YU J, Chen R, Tan Y, Wu J, et al
    Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice.
    PLoS One. 2016;11:e0166560.
    >> Share

  364. BRAGA LM, Prado GF, Umeda II, Kawauchi TS, et al
    Reproducibility for Heart Rate Variability Analysis during 6-Min Walk Test in Patients with Heart Failure and Agreement between Devices.
    PLoS One. 2016;11:e0167407.
    >> Share

  365. UEDA K, Kasao M, Shimamura M, Haruta H, et al
    Impact of Oral Treatment on Physical Function in Older Patients Hospitalized for Heart Failure: A Randomized Clinical Trial.
    PLoS One. 2016;11:e0167933.
    >> Share

  366. MARCONDES-BRAGA FG, Batista GL, Gutz IG, Saldiva PH, et al
    Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up.
    PLoS One. 2016;11:e0168790.
    >> Share

  367. KANEKO M, Hashikami K, Yamamoto S, Matsumoto H, et al
    Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model.
    PLoS One. 2016;11:e0168486.
    >> Share

  368. HAI JJ, Chan PH, Chan YH, Fong CH, et al
    Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry.
    PLoS One. 2016;11:e0169095.
    >> Share

  369. SUGIMOTO K, Yoshihisa A, Nakazato K, Jin Y, et al
    Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0165603.
    >> Share

  370. BING R, Chow V, Lau JK, Thomas L, et al
    Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study.
    PLoS One. 2016;11:e0168554.
    >> Share

  371. KOOPMAN C, Vaartjes I, van Dis I, Verschuren WM, et al
    Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007.
    PLoS One. 2016;11:e0166139.
    >> Share

  372. PEIYUAN H, Jingang Y, Haiyan X, Xiaojin G, et al
    The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients >/= 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.
    PLoS One. 2016;11:e0165672.
    >> Share

  373. COOKE CR
    Risk of Death Influences Regional Variation in Intensive Care Unit Admission Rates among the Elderly in the United States.
    PLoS One. 2016;11:e0166933.
    >> Share

  374. LEE KF, Tsai YT, Lin CY, Hsieh CB, et al
    Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    PLoS One. 2016;11:e0155602.
    >> Share

  375. WANG Q, Guo YZ, Zhang YT, Xue JJ, et al
    The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0157171.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016